
|Articles|January 21, 2021
Prime Global and Raremark Partner for Patients with Rare Diseases
Advertisement
Prime Global and Raremark have announced a partnership aiming to transform solutions for patients with rare diseases.
The partnership will combine Raremark’s Xperiome platform for patients with Prime Global’s 23 years of medical communications experience aiming to uncover insights into the entire patient journey that will allow the creation of a patient-centric drug development and commercialization programs.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Clears Itvisma as First Gene Therapy for Adolescents and Adults With SMA
2
ACT Brief: AI in Clinical Research, FDA Gene Therapy Approval, and High-Performing Hospital Partnerships
3
Investigative Site Investment, Preparedness, and Experience with Digital Solutions
4
How AI, Automation, and FSP Partners Are Reshaping Global Pharmacovigilance
5






.png)



.png)



.png)
.png)
